Molecular characterization and current treatment strategy of glioblastoma multiforme

Molecular Biomarkers & Diagnosis

ISSN: 2155-9929

Open Access

Molecular characterization and current treatment strategy of glioblastoma multiforme

2nd World Congress on Biomarkers & Clinical Research

12-14 September 2011 Baltimore, USA

Xiang Zhang, Wei Zhang, Weidong Cao, Gang Cheng, Yongqiang Zhang, Bo-lin Liu and Jin-xiang Cheng

Scientific Tracks Abstracts: J Mol Biomark Diagn

Abstract :

Glioblastoma multiforme (GBM) is the most frequent and aggressive primary brain tumor in human and is classifi ed by the WHO in the group of diff usely infi ltrative astrocytomas, representing the most malignant subtype of them. Th e aberrant genetic events and signaling pathways have been clearly demonstrated. Th ey are cellular, highly anaplastic, and morphologically highly heterogeneous tumors. Understanding the genetic alterations, specifi c molecular biomarkers and proliferative pathways might promote therapeutic development for the management of GBM. In this article, we review the molecular characterization of GBM cells and current treatment strategy, including gross or near-total resection of the tumor, followed by radiotherapy and concurrent chemotherapy, stereotactic brachytherapy and new targeted therapies. Th e multimodal approaches for the treatment of GBM improve the prognosis.

Google Scholar citation report
Citations: 2054

Molecular Biomarkers & Diagnosis received 2054 citations as per Google Scholar report

Molecular Biomarkers & Diagnosis peer review process verified at publons

Indexed In

arrow_upward arrow_upward